Open original FDA record ↗Recall record
- FDA identifier
- Z-0326-2026
- Company in FDA record
- Alcon Research LLC
- FDA classification date
- Oct 24, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for a weak seal in some units resulting in compromise in sterility.
Source facts
- Action
- Alcon notified consignees via letter on about 09/30/2025. Consignees were instructed to cease distribution of affected units to patients, review inventory to determine if affected units are on hand, dispose of all affected units, complete and return the response form, and forward the notification to other facilities or departments if product has been further distributed or transferred. For MARLO direct-to-patient shipments: As a part of our MARLO service, Alcon can notify patients who have received shipments directly from Alcon and initiate replacement on your behalf via the MARLO portal and app. You will receive a notification to opt in to this service in your ECP MARLO portal within the next week.
- Initiated
- 2025-09-30
- Root cause
- Process control
- Distribution
- Worldwide - US distribution in the states of Alabama, Arizona, Arkansas, Connecticut, Florida, Idaho, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New York, Oklahoma, Oregon, Tennessee, Texas, Washington and the country of Canada.
- Recall number
- Z-0326-2026
- Recall status
- Open, Classified
- CDRH record ID
- 216461
- FDA classified
- 2025-10-24
- Recall event number
- 97739